GoodRx Holdings (GDRX) Enterprise Value (2020 - 2026)

GoodRx Holdings has disclosed Enterprise Value across 7 years of filings, most recently posting $683.5 million for Q2 2026.

• In Q2 2026, Enterprise Value fell 53.68% year-over-year to $683.5 million; the TTM figure through Jun 2026 stood at $683.5 million (down 53.68% YoY), while the FY2025 annual figure was $662.4 million, down 50.26% from the prior year.
• Enterprise Value came in at $683.5 million for Q2 2026 at GoodRx Holdings, up from $425.9 million in the prior quarter.
• In the past five years, Enterprise Value ranged from a high of $6.8 billion in Q1 2022 to a low of $425.9 million in Q1 2026.
• Average Enterprise Value over 5 years is $1.7 billion, with a median of $1.4 billion recorded in 2023.
• Year-over-year, Enterprise Value plunged 92.74% in 2022 and jumped 80.07% in 2023.
• Over 5 years, Enterprise Value stood at $1.1 billion in 2022, then jumped by 80.07% to $2.0 billion in 2023, then tumbled by 32.33% to $1.3 billion in 2024, then tumbled by 50.26% to $662.4 million in 2025, then grew by 3.17% to $683.5 million in 2026.
• Per Business Quant data, the three most recent Enterprise Value figures were $683.5 million in Q2 2026, $425.9 million in Q1 2026, and $662.4 million in Q4 2025.